Bombay HC permits Johnson & Johnson to manufacture, sell baby powder

Published On 2023-01-14 11:49 GMT   |   Update On 2023-01-14 11:49 GMT
Advertisement

The Bombay High Court on Wednesday quashed two orders passed by the Maharashtra government revoking the license of Johnson & Johnson company to manufacture, sell and distribute its baby powder products, terming them as “stringent, unreasonable and unfair”.

A division bench of Justices Gautam Patel and S G Dige permitted the company to manufacture, sell and distribute the products.

The bench passed its order on a petition filed by the company challenging two orders of the state government – one dated September 15, 2022 cancelling the license and the second dated September 20, 2022 ordering it to immediately stop the manufacturing and sale of the baby powder product.

Advertisement

For more details, check out the link given below:

Bombay High Court Relief To Johnson & Johnson, Company Allowed To Manufacture, Sell Baby Powder


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News